These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27597145)

  • 1. Impact of genetic variation in the 5-HT transporter and receptor on platelet function in patients with stable CAD taking aspirin.
    Bajrangee A; Ryan N; Vangjeli C; Brennan M; Cox D; Shields DC; Fitzgerald D; Maree A
    Thromb Res; 2016 Oct; 146():51-55. PubMed ID: 27597145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
    Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.
    Greenberg BD; Tolliver TJ; Huang SJ; Li Q; Bengel D; Murphy DL
    Am J Med Genet; 1999 Feb; 88(1):83-7. PubMed ID: 10050973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.
    Anderson GM; Gutknecht L; Cohen DJ; Brailly-Tabard S; Cohen JH; Ferrari P; Roubertoux PL; Tordjman S
    Mol Psychiatry; 2002; 7(8):831-6. PubMed ID: 12232775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction.
    Coto E; Reguero JR; Alvarez V; Morales B; Batalla A; González P; Martín M; García-Castro M; Iglesias-Cubero G; Cortina A
    Clin Sci (Lond); 2003 Mar; 104(3):241-5. PubMed ID: 12605580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of copper-aspirin complex on platelet aggregation.
    Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
    Johnson BA; Javors MA; Roache JD; Seneviratne C; Bergeson SE; Ait-Daoud N; Dawes MA; Ma JZ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):209-16. PubMed ID: 17950969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease.
    Maree AO; Curtin RJ; Dooley M; Conroy RM; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2005 Oct; 46(7):1258-63. PubMed ID: 16198840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
    Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lack of genotype-phenotype relationship between platelet serotonin concentration and serotonin transporter gene promoter polymorphism in healthy subjects.
    Pivac N; Nedic G; Mustapic M; Babic A; Stipcevic T; Borovecki F; Hajnsek S; Muck-Seler D
    Neurosci Lett; 2009 Oct; 462(1):45-8. PubMed ID: 19573575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-1 haplotype modulates platelet response to aspirin.
    Maree AO; Curtin RJ; Chubb A; Dolan C; Cox D; O'Brien J; Crean P; Shields DC; Fitzgerald DJ
    J Thromb Haemost; 2005 Oct; 3(10):2340-5. PubMed ID: 16150050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
    Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
    Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual antiplatelet response during PCI: VerifyNow P2Y12 predicts myocardial necrosis and thromboxane B2 generation confirms wide variation in aspirin response.
    Good RI; McGarrity A; James TE; Miller H; McConnachie A; Goodall AH; Oldroyd KG
    Thromb Res; 2015 Jun; 135(6):1140-6. PubMed ID: 25746368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease.
    Würtz M; Grove EL; Kristensen SD; Hvas AM
    Heart; 2010 Mar; 96(5):368-71. PubMed ID: 19910291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The administration of a loading dose of aspirin to patients presenting with acute myocardial infarction while receiving chronic aspirin treatment reduces thromboxane A2-dependent platelet reactivity.
    Santos MT; Madrid I; Moscardo A; Latorre AM; Bonastre J; Ruano M; Valles J
    Platelets; 2014; 25(4):268-73. PubMed ID: 23909754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension.
    Marcos E; Fadel E; Sanchez O; Humbert M; Dartevelle P; Simonneau G; Hamon M; Adnot S; Eddahibi S
    Circ Res; 2004 May; 94(9):1263-70. PubMed ID: 15059929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calprotectin and platelet aggregation in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Pareek M; Kristensen SD; Hvas AM
    PLoS One; 2015; 10(5):e0125992. PubMed ID: 25970343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients.
    Lepäntalo A; Mikkelsson J; Reséndiz JC; Viiri L; Backman JT; Kankuri E; Karhunen PJ; Lassila R
    Thromb Haemost; 2006 Feb; 95(2):253-9. PubMed ID: 16493486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.